S G O Johansson Selected Research

Neuromuscular Blocking Agents

5/2017	Six years without pholcodine; Norwegians are significantly less IgE-sensitized and clinically more tolerant to neuromuscular blocking agents.
7/2012	The Pholcodine Case. Cough Medicines, IgE-Sensitization, and Anaphylaxis: A Devious Connection.
7/2011	IgE-sensitization to the cough suppressant pholcodine and the effects of its withdrawal from the Norwegian market.
4/2010	National pholcodine consumption and prevalence of IgE-sensitization: a multicentre study.
8/2009	The pholcodine story.
9/2008	IgE-mediated anaphylactic reactions to neuromuscular blocking agents: can they be prevented?
12/2007	Pholcodine exposure raises serum IgE in patients with previous anaphylaxis to neuromuscular blocking agents.
11/2007	No consumption of IgE antibody in serum during allergic drug anaphylaxis.
1/2006	Pholcodine stimulates a dramatic increase of IgE in IgE-sensitized individuals. A pilot study.
4/2005	Prevalence of IgE antibodies to morphine. Relation to the high and low incidences of NMBA anaphylaxis in Norway and Sweden, respectively.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

S G O Johansson Research Topics

Disease

21	Hypersensitivity (Allergy) 10/2019 - 11/2002
19	Anaphylaxis (Anaphylactic Shock) 05/2017 - 11/2002
11	Asthma (Bronchial Asthma) 01/2016 - 08/2002
7	Cough 07/2012 - 04/2005
4	Food Hypersensitivity (Food Allergy) 04/2017 - 11/2002
3	Peanut Hypersensitivity (Peanut Allergy) 04/2017 - 02/2012
3	Inflammation (Inflammations) 01/2015 - 03/2006
3	Allergic Rhinitis 01/2013 - 08/2002
2	Eczema 07/2005 - 11/2002
2	Atopic Dermatitis (Atopic Eczema) 07/2005 - 11/2002
1	Milk Hypersensitivity (Milk Allergy) 10/2014
1	Seasonal Allergic Rhinitis (Hay Fever) 11/2013
1	Wheat Hypersensitivity (Wheat Allergy) 01/2013
1	Breast Neoplasms (Breast Cancer) 01/2010
1	Neoplasms (Cancer) 01/2010
1	Nasal Polyps (Nasal Polyp) 01/2005
1	Polyps 01/2005
1	Bird Fancier's Lung 06/2004
1	Conjunctivitis 11/2002
1	Dermatitis 11/2002
1	Food Intolerance 11/2002
1	Rhinitis 08/2002

Drug/Important Bio-Agent (IBA)

33	Immunoglobulin E (IgE)IBA 05/2017 - 08/2002
20	AntibodiesIBA 05/2017 - 11/2002
12	AllergensIBA 09/2015 - 11/2002
10	Neuromuscular Blocking AgentsIBA 05/2017 - 04/2005
9	Omalizumab (Xolair)FDA Link 10/2019 - 08/2002
9	pholcodineIBA 05/2017 - 04/2005
4	Succinylcholine (Suxamethonium Chloride)FDA LinkGeneric 05/2017 - 01/2006
4	EpitopesIBA 05/2017 - 03/2007
4	Immunoglobulins (Immunoglobulin)IBA 01/2016 - 07/2005
3	Ammonium CompoundsIBA 05/2017 - 12/2007
2	hypoxanthine arabinoside (ara-H)IBA 01/2015 - 11/2013
2	Morphine (MS Contin)FDA LinkGeneric 04/2010 - 01/2006
2	Immunoglobulin G (IgG)IBA 01/2010 - 06/2004
2	sulfan blue (patent blue V)IBA 01/2010 - 01/2010
2	anti-IgE antibodiesIBA 10/2009 - 08/2002
2	Enterotoxins (Enterotoxin)IBA 01/2005 - 05/2003
1	ReaginsIBA 01/2016
1	Proteins (Proteins, Gene)FDA Link 01/2015
1	Lactalbumin (alpha-Lactalbumin)IBA 10/2014
1	Caseins (Casein)FDA Link 10/2014
1	Milk Proteins (Milk Protein)IBA 10/2014
1	Complement System Proteins (Complement)IBA 01/2013
1	Biological ProductsIBA 07/2012
1	Atracurium (Tracrium)FDA Link 02/2012
1	Methacholine Chloride (Methacholine)FDA Link 08/2011
1	Coloring Agents (Dyes)IBA 01/2010
1	Tryptases (Tryptase)IBA 01/2010
1	Guaifenesin FDA LinkGeneric 12/2007
1	Pharmaceutical PreparationsIBA 11/2007
1	LatexIBA 06/2007
1	CarbohydratesIBA 03/2007
1	A-factor (Streptomyces)IBA 03/2006

Therapy/Procedure

3	Immunotherapy 10/2019 - 05/2009
2	General Anesthesia 07/2012 - 08/2009
1	Anesthesia 01/2010
1	Aftercare (After-Treatment) 01/2010
1	Cesarean Section (Caesarean Section) 06/2007
1	Blood Transfusion (Blood Transfusions) 03/2006